Translational neuroimmunology review series (2014)

Series Editors: Olaf Stüve and Uwe Zettl

Editorial
Neuroinflammation of the central and peripheral nervous system: an update
O Stüve and U Zettl

Review Articles
Paraneoplastic neurological syndromes
F Leypoldt and K.-P Wandinger

Diagnosis, pathogenesis and treatment of myositis: recent advances
P-O. Carstens and J Schmidt

Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies
N Melzer and SG Meuth

Monoclonal antibodies in treatment of multiple sclerosis
PS Rommer, A Dudesek, O Stüve and UK Zettl

CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders
A Dudesek, F Rimmele, S Tesar, S Kolbaske, PS Rommer, R Benecke and UK Zettl

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
PS Rommer, UK Zettl, B Kieseier, H-P Hartung, T Menge, E Frohman, BM Greenberg, B Hemmer and O Stüve

Myasthenia gravis: an update for the clinician
JP Sieb

Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls
P Berlit and M Kraemer

Multiple sclerosis treatment and infectious issues: update 2013
A Winkelmann, M Loebermann, EC Reisinger and UK Zettl

Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system
A Salmen, R Gold and A Cha

Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S Jarius, B Wildemann and F Paul

If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it?
DP Eisen and M Osthoff